Production (Stage)
Nektar Therapeutics
NKTR
$0.666
-$0.0088-1.30%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 218.63M | 255.23M | 244.50M | 271.24M | 289.24M |
| Total Receivables | 1.71M | 1.61M | 2.12M | 2.90M | 5.43M |
| Inventory | -- | -- | -- | 14.47M | 16.24M |
| Prepaid Expenses | 2.21M | 2.51M | 2.85M | 2.38M | 4.16M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 7.36M | 1.95M | 37.01M | 4.21M | 4.77M |
| Total Current Assets | 229.91M | 261.29M | 286.48M | 295.19M | 319.84M |
|
|
|||||
| Total Current Assets | 229.91M | 261.29M | 286.48M | 295.19M | 319.84M |
| Net Property, Plant & Equipment | 11.16M | 11.82M | 12.43M | 24.43M | 34.74M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.39M | 4.65M | 4.52M | 4.31M | 4.66M |
| Total Assets | 256.24M | 303.85M | 307.97M | 343.33M | 396.01M |
|
|
|||||
| Total Accounts Payable | 17.83M | 11.56M | 8.58M | 6.48M | 8.76M |
| Total Accrued Expenses | 28.43M | 27.21M | 29.23M | 26.16M | 19.93M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 21.84M | 19.87M | 21.50M | 21.34M | 19.37M |
| Total Finance Division Other Current Liabilities | 2.83M | 2.77M | 8.28M | 3.36M | 4.35M |
| Total Other Current Liabilities | 2.83M | 2.77M | 8.28M | 3.36M | 4.35M |
| Total Current Liabilities | 70.93M | 61.40M | 67.58M | 57.33M | 52.41M |
|
|
|||||
| Total Current Liabilities | 70.93M | 61.40M | 67.58M | 57.33M | 52.41M |
| Long-Term Debt | 86.32M | 91.78M | 97.83M | 107.51M | 117.86M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 78.50M | 82.70M | 86.76M | 90.76M | 94.71M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 6.76M | 7.24M | 6.91M | 8.05M | 4.33M |
| Total Liabilities | 242.50M | 243.11M | 259.08M | 263.65M | 269.31M |
|
|
|||||
| Common Stock & APIC | 3.66B | 3.66B | 3.66B | 3.65B | 3.64B |
| Retained Earnings | -3.65B | -3.60B | -3.60B | -3.57B | -3.51B |
| Treasury Stock & Other | -2.96M | -2.94M | -2.65M | -3.49M | -3.40M |
| Total Common Equity | 13.74M | 60.74M | 48.88M | 79.69M | 126.71M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 13.74M | 60.74M | 48.88M | 79.69M | 126.71M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 13.74M | 60.74M | 48.88M | 79.69M | 126.71M |
|
|
|||||